Company Filing History:
Years Active: 2009
Title: The Innovative Mind of Kyoung-a Kim
Introduction
Kyoung-a Kim, an inventive researcher based in Gwangmyeong-si, South Korea, has made significant strides in the field of genetics and disease association studies. With a focus on single nucleotide polymorphisms (SNPs), his work is paving the way for advancements in personalized medicine.
Latest Patents
Kim is the holder of a notable patent titled "Method of selecting optimized SNP marker sets from multiple SNP markers associated with a complex disease." This innovative method provides a systematic approach for selecting an optimized SNP marker set from a wide array of markers. The process involves selecting high-association SNP markers using set-association techniques, conducting discrimination analysis, and employing receiver operating characteristic (ROC) curve analysis to refine selections based on predetermined criteria. This patent represents a meaningful contribution to the field as it enhances the accuracy of SNP marker selection in complex diseases.
Career Highlights
Currently employed at Samsung Electronics Co., Ltd., Kyoung-a Kim has established himself as a leading inventor in his domain. His innovative methodologies reflect throughout his professional journey, showcasing a dedication to advancing genetic research and contributing to the understanding of complex diseases.
Collaborations
Throughout his career, Kim has collaborated with talented colleagues such as Kyung-hee Park and Kyu-sang Lee. These partnerships foster a dynamic research environment that encourages the sharing of ideas and expertise, driving forward their collective goals in genetic research and technology development.
Conclusion
Kyoung-a Kim exemplifies the spirit of innovation within the research community. His contributions, marked by a significant patent and collaborative efforts, highlight the importance of continuous exploration and advancement in the understanding of genetic health. As he continues to develop his methodologies, the potential for breakthroughs in complex disease research remains promising.